Literature DB >> 15838578

Seroprevalence of hepatitis B virus and hepatitis C virus in Monte Negro in the Brazilian western Amazon region.

Marcelo El Khouri1, Leandro Savoy Duarte, Rafael Bernadon Ribeiro, Luis Fernando Ferraz da Silva, Luis Marcelo Aranha Camargo, Vera Aparecida dos Santos, Marcelo Nascimento Burattini, Carlos Eduardo Pereira Corbett.   

Abstract

PURPOSE: This study was carried out in Monte Negro (state of Rondônia), a village in the Brazilian western Amazon region, where a University of São Paulo Medical School program for medical student training in rural assistance took place. It aimed to determine the prevalence of hepatitis B virus and hepatitis C virus, to investigate risk factors for infection, and to evaluate the State immunization program against hepatitis B virus in the region.
METHODS: The study is a cross-sectional seroprevalence survey, comprising 267 volunteers who answered a comprehensive questionnaire and had blood samples collected, which were analyzed in São Paulo for the presence of antibodies against hepatitis B virus (Hbs Ag, anti-Hbs, and anti-Hbc) and hepatitis C virus using commercial kits. Data were stored in a specific data bank, and the association between seropositivity and potential risk factors was analyzed by means of uni-, bi-, and multi-variate analysis, considering +/- 5%.
RESULTS: The seroprevalence of hepatitis B virus was 61.79% and of hepatitis C virus was 0.38%. Statistical analysis on the data bank showed that the prevalence of hepatitis B virus rose significantly with age, especially after adolescence. Infection was higher in those coming from outside the state of Rondônia. Exposure to vaccination against hepatitis B virus was higher in younger individuals and in those who were born in Rondônia.
CONCLUSION: Monte Negro is a highly endemic region for hepatitis B virus but not for hepatitis C virus. Our results also provide indirect evidence indicating a significant improvement in the immunization program in Rondônia in recent years.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838578     DOI: 10.1590/s1807-59322005000100007

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN: 1807-5932            Impact factor:   2.365


  3 in total

1.  Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019.

Authors:  Shelina Moonsamy; Melinda Suchard; Pavitra Pillay; Nishi Prabdial-Sing
Journal:  BMC Public Health       Date:  2022-01-06       Impact factor: 3.295

2.  Regional differences and temporal trend analysis of Hepatitis B in Brazil.

Authors:  Giuliano Grandi; Luis Fernandez Lopez; Marcelo Nascimento Burattini
Journal:  BMC Public Health       Date:  2022-10-17       Impact factor: 4.135

3.  Population-Based Multicentric Survey of Hepatitis B Infection and Risk Factors in the North, South, and Southeast Regions of Brazil, 10-20 Years After the Beginning of Vaccination.

Authors:  Ricardo A A Ximenes; Gerusa M Figueiredo; Maria Regina A Cardoso; Airton T Stein; Regina C Moreira; Gabriela Coral; Deborah Crespo; Alex A Dos Santos; Ulisses R Montarroyos; Maria Cynthia Braga; Leila M M B Pereira
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.